Skip to main content

Table 1 Study population characteristics

From: Effects of paraoxonase activity and gene polymorphism on coronary vasomotion

Variable (n= 19)

Mean ± SD or median (IQR) or n(%)

Age (years)

57.6 ± 9.8

Sex (% of women)

8 Women/11 men (42% women)

Weight (kg)

77 (66-94)

Body mass index (kg/m2)

25.9 (22.1-30.9)

Current smoking

3 (16%)

Hypertension

15 (80%)

Dyslipidemia

12 (63%)

Family history of early CHD

0 (0%)

Overall cholesterol (mmol/L)

4.2 ± 0.8

LDL-cholesterol (mmol/L)

2.3 ± 0.7

HDL-cholesterol (mmol/L)

1.2 ± 0.3

Triglyceride levels (mmol/L)

1.2 (0.9-1.8)

Fastening insulin (μU/mL)

10.8 (6.9-21.6)

Fastening glucose (mmol/L)

5.8 (5.4-7.5)

HOMA-IR (1)

3.3 (1.8-5.0)

hsCRP (mg/L, normal < 5 mg/L)

1.1 (0.4-2.8)

PON1 (U/L; n = 18)

79.3 ± 71.7

Arylesterase (U/L; n = 18)

41.0 (38.9-48.3)

Ratio hsCRP/PON1 × 1,000 (mg/U; n = 18)

47.1 (7.3-312)

  1. IQR, interquartile range; CHD, coronary heart disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; hsCRP, high sensitivity C-reactive protein.